High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization

Baogen Zhang, Biqing Huang, Fan Yang, Jiandong Yang, Man Kong, Jing Wang, Yaoxian Xiang, Kangjie Wang, Ruchen Peng, Kun Yang, Chao An, Dong YanJournal of Hepatocellular Carcinoma 2024 · DOI

Abstract

HAIC can provide better disease control for hHCC than cTACE, with a comparable long-term OS and safety.
BibTeX
@article{zhang2024high,
  author = {Baogen Zhang and Biqing Huang and Fan Yang and Jiandong Yang and Man Kong and Jing Wang and Yaoxian Xiang and Kangjie Wang and Ruchen Peng and Kun Yang and Chao An and Dong Yan},
  title = {{High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization}},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2024},
  doi = {10.2147/jhc.s455953},
}

Loading related content...

Figure